Kaposi sarcoma-associated herpesvirus promotes tumorigenesis by modulating the Hippo pathway

G. Liu, F. X. Yu, Y. C. Kim, Z. Meng, J. Naipauer, D. J. Looney, X. Liu, J. S. Gutkind, Enrique A Mesri, K. L. Guan

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Kaposi sarcoma-associated herpesvirus (KSHV) is an oncogenic virus and the culprit behind the human disease Kaposi sarcoma (KS), an AIDS-defining malignancy. KSHV encodes a viral G-protein-coupled receptor (vGPCR) critical for the initiation and progression of KS. In this study, we identified that YAP/TAZ, two homologous oncoproteins inhibited by the Hippo tumor suppressor pathway, are activated in KSHV-infected cells in vitro, KS-like mouse tumors and clinical human KS specimens. The KSHV-encoded vGPCR acts through Gq/11 and G12/13 to inhibit the Hippo pathway kinases Lats1/2, promoting the activation of YAP/TAZ. Furthermore, depletion of YAP/TAZ blocks vGPCR-induced cell proliferation and tumorigenesis in a xenograft mouse model. The vGPCR-transformed cells are sensitive to pharmacologic inhibition of YAP. Our study establishes a pivotal role of the Hippo pathway in mediating the oncogenic activity of KSHV and development of KS, and also suggests a potential of using YAP inhibitors for KS intervention.

Original languageEnglish (US)
Pages (from-to)3536-3546
Number of pages11
JournalOncogene
Volume34
Issue number27
DOIs
StatePublished - Jul 1 2015

Fingerprint

Human Herpesvirus 8
Kaposi's Sarcoma
Carcinogenesis
Viral Proteins
G-Protein-Coupled Receptors
Neoplasms
Oncogenic Viruses
Oncogene Proteins
Heterografts
Acquired Immunodeficiency Syndrome
Phosphotransferases
Cell Proliferation

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

Liu, G., Yu, F. X., Kim, Y. C., Meng, Z., Naipauer, J., Looney, D. J., ... Guan, K. L. (2015). Kaposi sarcoma-associated herpesvirus promotes tumorigenesis by modulating the Hippo pathway. Oncogene, 34(27), 3536-3546. https://doi.org/10.1038/onc.2014.281

Kaposi sarcoma-associated herpesvirus promotes tumorigenesis by modulating the Hippo pathway. / Liu, G.; Yu, F. X.; Kim, Y. C.; Meng, Z.; Naipauer, J.; Looney, D. J.; Liu, X.; Gutkind, J. S.; Mesri, Enrique A; Guan, K. L.

In: Oncogene, Vol. 34, No. 27, 01.07.2015, p. 3536-3546.

Research output: Contribution to journalArticle

Liu, G, Yu, FX, Kim, YC, Meng, Z, Naipauer, J, Looney, DJ, Liu, X, Gutkind, JS, Mesri, EA & Guan, KL 2015, 'Kaposi sarcoma-associated herpesvirus promotes tumorigenesis by modulating the Hippo pathway', Oncogene, vol. 34, no. 27, pp. 3536-3546. https://doi.org/10.1038/onc.2014.281
Liu G, Yu FX, Kim YC, Meng Z, Naipauer J, Looney DJ et al. Kaposi sarcoma-associated herpesvirus promotes tumorigenesis by modulating the Hippo pathway. Oncogene. 2015 Jul 1;34(27):3536-3546. https://doi.org/10.1038/onc.2014.281
Liu, G. ; Yu, F. X. ; Kim, Y. C. ; Meng, Z. ; Naipauer, J. ; Looney, D. J. ; Liu, X. ; Gutkind, J. S. ; Mesri, Enrique A ; Guan, K. L. / Kaposi sarcoma-associated herpesvirus promotes tumorigenesis by modulating the Hippo pathway. In: Oncogene. 2015 ; Vol. 34, No. 27. pp. 3536-3546.
@article{c4add526db28412a89edbde6a9fc955e,
title = "Kaposi sarcoma-associated herpesvirus promotes tumorigenesis by modulating the Hippo pathway",
abstract = "Kaposi sarcoma-associated herpesvirus (KSHV) is an oncogenic virus and the culprit behind the human disease Kaposi sarcoma (KS), an AIDS-defining malignancy. KSHV encodes a viral G-protein-coupled receptor (vGPCR) critical for the initiation and progression of KS. In this study, we identified that YAP/TAZ, two homologous oncoproteins inhibited by the Hippo tumor suppressor pathway, are activated in KSHV-infected cells in vitro, KS-like mouse tumors and clinical human KS specimens. The KSHV-encoded vGPCR acts through Gq/11 and G12/13 to inhibit the Hippo pathway kinases Lats1/2, promoting the activation of YAP/TAZ. Furthermore, depletion of YAP/TAZ blocks vGPCR-induced cell proliferation and tumorigenesis in a xenograft mouse model. The vGPCR-transformed cells are sensitive to pharmacologic inhibition of YAP. Our study establishes a pivotal role of the Hippo pathway in mediating the oncogenic activity of KSHV and development of KS, and also suggests a potential of using YAP inhibitors for KS intervention.",
author = "G. Liu and Yu, {F. X.} and Kim, {Y. C.} and Z. Meng and J. Naipauer and Looney, {D. J.} and X. Liu and Gutkind, {J. S.} and Mesri, {Enrique A} and Guan, {K. L.}",
year = "2015",
month = "7",
day = "1",
doi = "10.1038/onc.2014.281",
language = "English (US)",
volume = "34",
pages = "3536--3546",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "27",

}

TY - JOUR

T1 - Kaposi sarcoma-associated herpesvirus promotes tumorigenesis by modulating the Hippo pathway

AU - Liu, G.

AU - Yu, F. X.

AU - Kim, Y. C.

AU - Meng, Z.

AU - Naipauer, J.

AU - Looney, D. J.

AU - Liu, X.

AU - Gutkind, J. S.

AU - Mesri, Enrique A

AU - Guan, K. L.

PY - 2015/7/1

Y1 - 2015/7/1

N2 - Kaposi sarcoma-associated herpesvirus (KSHV) is an oncogenic virus and the culprit behind the human disease Kaposi sarcoma (KS), an AIDS-defining malignancy. KSHV encodes a viral G-protein-coupled receptor (vGPCR) critical for the initiation and progression of KS. In this study, we identified that YAP/TAZ, two homologous oncoproteins inhibited by the Hippo tumor suppressor pathway, are activated in KSHV-infected cells in vitro, KS-like mouse tumors and clinical human KS specimens. The KSHV-encoded vGPCR acts through Gq/11 and G12/13 to inhibit the Hippo pathway kinases Lats1/2, promoting the activation of YAP/TAZ. Furthermore, depletion of YAP/TAZ blocks vGPCR-induced cell proliferation and tumorigenesis in a xenograft mouse model. The vGPCR-transformed cells are sensitive to pharmacologic inhibition of YAP. Our study establishes a pivotal role of the Hippo pathway in mediating the oncogenic activity of KSHV and development of KS, and also suggests a potential of using YAP inhibitors for KS intervention.

AB - Kaposi sarcoma-associated herpesvirus (KSHV) is an oncogenic virus and the culprit behind the human disease Kaposi sarcoma (KS), an AIDS-defining malignancy. KSHV encodes a viral G-protein-coupled receptor (vGPCR) critical for the initiation and progression of KS. In this study, we identified that YAP/TAZ, two homologous oncoproteins inhibited by the Hippo tumor suppressor pathway, are activated in KSHV-infected cells in vitro, KS-like mouse tumors and clinical human KS specimens. The KSHV-encoded vGPCR acts through Gq/11 and G12/13 to inhibit the Hippo pathway kinases Lats1/2, promoting the activation of YAP/TAZ. Furthermore, depletion of YAP/TAZ blocks vGPCR-induced cell proliferation and tumorigenesis in a xenograft mouse model. The vGPCR-transformed cells are sensitive to pharmacologic inhibition of YAP. Our study establishes a pivotal role of the Hippo pathway in mediating the oncogenic activity of KSHV and development of KS, and also suggests a potential of using YAP inhibitors for KS intervention.

UR - http://www.scopus.com/inward/record.url?scp=84939417563&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84939417563&partnerID=8YFLogxK

U2 - 10.1038/onc.2014.281

DO - 10.1038/onc.2014.281

M3 - Article

VL - 34

SP - 3536

EP - 3546

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 27

ER -